Detalhe da pesquisa
1.
Safety and feasibility of single-port nephroscopy combined with a needle electrode technique to treat dorsal SRCs.
Urol Int
; 2024 Mar 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38537617
2.
N6-methyladenosine modified lncRNAs signature for stratification of biochemical recurrence in prostate cancer.
Hum Genet
; 2023 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37758909
3.
Ginsenoside Rh2 Inhibits Angiogenesis in Prostate Cancer by Targeting CNNM1.
J Nanosci Nanotechnol
; 19(4): 1942-1950, 2019 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30486934
4.
MicroRNA-224 and its target CAMKK2 synergistically influence tumor progression and patient prognosis in prostate cancer.
Tumour Biol
; 36(3): 1983-91, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25394900
5.
Overexpression of NIMA-related kinase 2 is associated with progression and poor prognosis of prostate cancer.
BMC Urol
; 15: 90, 2015 Aug 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-26320076
6.
MicroRNA-224 inhibits progression of human prostate cancer by downregulating TRIB1.
Int J Cancer
; 135(3): 541-50, 2014 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24382668
7.
Estimation of the tumor size at cure threshold among adult patients with adrenocortical carcinoma: A populational-based study.
Heliyon
; 10(7): e28160, 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38571632
8.
Analysis of the origin and invasion of prostate cancer from autopsy and radical prostatectomy specimens.
Transl Cancer Res
; 13(2): 651-660, 2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38482427
9.
Biparametric MRI-based radiomics classifiers for the detection of prostate cancer in patients with PSA serum levels of 4â¼10 ng/mL.
Front Oncol
; 12: 1020317, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36582803
10.
Genome-Scale CRISPR-Cas9 Transcriptional Activation Screening in Metformin Resistance Related Gene of Prostate Cancer.
Front Cell Dev Biol
; 8: 616332, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33575255
11.
miR30c suppresses prostate cancer survival by targeting the ASF/SF2 splicing factor oncoprotein.
Mol Med Rep
; 16(3): 2431-2438, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28677791
12.
Elevated expression of IMPDH2 is associated with progression of kidney and bladder cancer.
Med Oncol
; 32(1): 373, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25465060
13.
Clinical performance of serum [-2]proPSA derivatives, %p2PSA and PHI, in the detection and management of prostate cancer.
Am J Clin Exp Urol
; 2(4): 343-50, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25606581
14.
Combined overexpression of HIVEP3 and SOX9 predicts unfavorable biochemical recurrence-free survival in patients with prostate cancer.
Onco Targets Ther
; 7: 137-46, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24493929
15.
Decreased expression of myosin light chain MYL9 in stroma predicts malignant progression and poor biochemical recurrence-free survival in prostate cancer.
Med Oncol
; 31(1): 820, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24338276